FEED
ENvue Medical, Inc. NASDAQ$1.14
Mkt Cap $1.3M
52w Low $1.00
2.7% of range
52w High $5.98
50d MA $4.00
200d MA $4.00
P/E (TTM)
-0.1x
EV/EBITDA
0.1x
P/B
0.0x
Debt/Equity
0.0x
ROE
-54.3%
P/FCF
-0.2x
RSI (14)
—
ATR (14)
—
Beta
2.10
50d MA
$4.00
200d MA
$4.00
Avg Volume
7.6M
About
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Recent Filings
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
The late annual report filing signals potential financial or operational distress at FEED, suggesting management challenges that could trigger delisting risk or shareholder value destruction if not promptly resolved.
Mar 31
8-K · 5.02
!!! Very High
ENvue Medical, Inc. -- 8-K 5.02: Executive Change
ENvue Medical (FEED) experienced a management change as director Doron Besser resigned, which could signal internal shifts though the impact depends on his specific responsibilities and replacement plans.
Feb 6
Data updated apr 25, 2026 8:49am
· Source: massive.com